The University of Chicago Header Logo

Connection

Thomas Gajewski to Indoleamine-Pyrrole 2,3,-Dioxygenase

Back to Details
This is a "connection" page, showing publications Thomas Gajewski has written about Indoleamine-Pyrrole 2,3,-Dioxygenase.
Thomas Gajewski
Connection Strength
0.490
Indoleamine-Pyrrole 2,3,-Dioxygenase
  1. First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies. Clin Cancer Res. 2017 07 01; 23(13):3269-3276.
    View in: PubMed
    Score: 0.490
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.